Itolizumab use for coronavirus encouraging, says Biocon

Biocon has witnessed encouraging results in the use of its novel
biologic Itolizumab for treating some Covid-19 related conditions, the
pharmaceutical company said on Friday. Biocon said the first set of
trials using the drug were done in Mumbai and Delhi.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/itolizumab-use-for-coronavirus-encouraging-says-biocon/articleshow/75766590.cms

Comments

Popular posts from this blog

Pharma Production Executive Post Vacancy @ Intas

Pharos of Chaos

HILR Intersession: Mollie Crawford-Volk: Velazquez' "Las Meninas" and its Modern Progeny